Integrated Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System

May 18, 2009 updated by: National Taiwan University Hospital

Integrated a Novel Clinical Decision Support System (CDSS) in a Computerized Physician Order Entry System

The purpose of this study is to understand the impact of CDSS by knowing the prescribers actions to the CDSS, also the influence of prescribing error announced by pharmacists.

Study Overview

Status

Unknown

Detailed Description

  1. To assess the sensitivity of the CDSS which could identify some specific prescribing errors (ex: duplication of drugs, dosage that exceed the maximum dose,prescribes drugs that have drug-drug interactions).
  2. To identify what kind of drugs are most likely to cause duplication use by the physicians, and what kind of drugs are most likely to exceed the maximum dosage, also to know what kind of drugs are most likely to cause drug-drug interaction that physicians encounter during prescribing.
  3. To evaluate the percentage of physician acceptance of the prescribing errors identify by the CDSS.
  4. What's the impact of CDSS on pharmacist announced prescribing error.

Study Type

Observational

Enrollment (Anticipated)

50000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Recruiting
        • National Taiwan University Hospital Taipei, Taiwan
        • Contact:
        • Principal Investigator:
          • Fe-Lin Lin Wu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The prescriptions which induced the alert windows pop out.

Description

Inclusion Criteria:

  • The prescriptions which induced the alert windows pop out.

Exclusion Criteria:

  • The prescriptions which not induced the alert windows pop out.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
accepted
The suggestions provided by the CDSS which were accepted by the physicians.
denied
The suggestions provided by the CDSS which were denied by the physicians.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fe-Lin Lin Wu, Associate Professor, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2009

Study Registration Dates

First Submitted

May 17, 2009

First Submitted That Met QC Criteria

May 18, 2009

First Posted (ESTIMATE)

May 19, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

May 19, 2009

Last Update Submitted That Met QC Criteria

May 18, 2009

Last Verified

May 1, 2009

More Information

Terms related to this study

Other Study ID Numbers

  • 20080306OR

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Evaluate the Impact of the CDSS

3
Subscribe